Updated 2026-02-12 · NCT06760546See eligibility →
Sponsor
Clinical trials sponsored by Rhythm Pharmaceuticals, Inc.
Active studies whose public registry record names Rhythm Pharmaceuticals, Inc. as lead sponsor.
5active studies
2recruiting now
6countries represented
28largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowPhase 1, Phase 2
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Updated 2025-12-22 · NCT06239116See eligibility →
Invitation onlyPhase 2
A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
Updated 2026-02-10 · NCT07156578See eligibility →
Active, not recruitingPhase 3
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Updated 2026-08-10 · NCT05774756See eligibility →
Active, not recruitingPhase 2
A Study of Setmelanotide in Patients With Prader-Willi Syndrome
Updated 2026-02-12 · NCT06772597See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.